<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UI-Indonesia_Parts skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UI-Indonesia/Parts</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Home - Hi,Vax! UI iGEM Team 2016</TITLE></P><DIV id="nav-box"><DIV id="cssmenu"><UL><LI><A href="https://2016.igem.org/team:UI-Indonesia">Home</A></LI><LI><A href="https://2016.igem.org/team:UI-Indonesia/Description">Our Project</A></LI><LI class="has-sub active"><A href="#">Part</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/Basic_Part">Basic Part</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/Parts">Part</A></LI></UL><LI><A href="https://2016.igem.org/team:UI-Indonesia/Model">Modelling</A></LI><LI class="has-sub"><A href="#">Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/HP/Silver">Field Activities</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/HP/Gold">Hand Book</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/Integrated_Practice">Integrated Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/Engagement">Education and Public Engagement</A></LI><LI><A href="https://2016.igem.org/team:UI-Indonesia/Medal_Criteria">Medal Criteria</A></LI><LI><A href="https://2016.igem.org/team:UI-Indonesia/Team">Team</A></LI><LI class="has-sub"><A href="#">References</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:UI-Indonesia/Attributions">Attributions</A></LI><LI><A href="#">Photo Collection</A></LI></DIV></DIV><SECTION class="contents" id=""><DIV class="container"><DIV class="row"><H2 class="text-center">Parts</H2><H3><CENTER> Enhanced green fluorescent protein (EGFP) coding sequence (human-optimized) </CENTER></H3><B><H3 class="text-center"><A href="http://parts.igem.org/Part:BBa_K2050420">BBa_K2050420</A></H3></B><P>The green fluorescent protein (GFP) is a protein originally obtained from the jellyfish Aequorea victoria that emits green fluorescence upon exposure to light in the blue to ultraviolet range and is typically used in molecular biology and genetics as a reporter. The enhanced GFP (or EGFP) was developed to allow for its practical usage in mammalian cells.</P><B><H3 class="text-center"> Thosea Asigna Virus 2A peptide linker (T2A) </H3></B><B><H3 class="text-center"><A href="http://parts.igem.org/Part:BBa_K2050421">BBa_K2050421</A></H3></B><P>2A peptide is a self-cleaving peptide linker. The sequence encoding the 2A peptide is typically included between the coding sequences of two proteins without stop codons to co-express the two proteins in a single vector. The two coding sequences will be transcribed onto one mRNA molecule along with the coding sequence for the 2A peptide. During translation, however, the peptide will cleave the peptide bond between the glycine and the proline residue on its C-terminus. The result is two different polypeptide chains.</P><P>The coding sequence for 2A peptide is far shorter than that of an IRES, making it preferable in constructing a multicistronic vector. The consequence of using the 2A peptide linker, however, is that the upstream protein will have additional residues from the 2A peptide on its C-terminus and the downstream protein will start with a proline</P><B><H3 class="text-center"> Mouse H1 promoter (RNA Polymerase III promoter) </H3></B><B><H3 class="text-center"><A href="http://parts.igem.org/Part:BBa_K2050422">BBa_K2050422</A></H3></B><P>RNA polymerase III is responsible for transcribing small RNA molecules including the 5S rRNA and tRNAs. RNA polymerase III promoters, including the H1 promoter, is useful in creating synthetic functional RNA-encoding genes. RNA polymerase III promoters are considerably smaller than RNA polymerase II promoters and initiates expression at ten times the rate RNA polymerase II promoters do. Examples on using functional RNA genes include miRNA expression, guide RNA expression for CRISPR technology, and immunostimulatory RNA (isRNA) expression, the latter used in many projects (including ours) on vaccination.</P><P>The use of RNA molecules as a vaccine adjuvant hinges on the interaction of those RNA molecules with the retinoic acid-inducible gene 1 (RIG-1) receptor, which is a pathogen-associated molecular pattern recognition receptor specialized in detecting non-self RNA molecules and triggering the innate immunity upon recognizing such molecules. The presence of 5'-PPP on these molecules distinguish them from self RNA molecules, in which the 5'-PPP is usually moved or masked. Because RNA polymerase III transcription does not initiate 5-capping like RNA polymerase II transcription does, the use of RNA polymerase III promoters have this as an additional advantage for isRNA expression. The use of a mouse H1 promoter instead of that of human is preferable for human applications as it limits the probability for homologous recombination with the human genome.</P><B><H3 class="text-center"> tRNA(Val) and linker </H3></B><B><H3 class="text-center"><A href="http://parts.igem.org/Part:BBa_K2050423">BBa_K2050423</A></H3></B><P>The tRNA(Val) and linker can be used to facilitate the export of a functional non-coding RNA into the cytosol (using the inherent tRNA export mechanism).</P><B><H3 class="text-center"> Adenoviral VA1 RNA gene </H3></B><B><H3 class="text-center"><A href="http://parts.igem.org/Part:BBa_K2050424">BBa_K2050424</A></H3></B><P>The VA1 RNA gene is an RNA polymerase III-driven gene that encodes the viral RNA VA1. By its nature, the RNA molecule facilitates infection by inhibiting the protein kinase R response, which is activated in infected cells and acts to globally suppress gene expression to inhibit viral replication. Co-expressing the VA1 RNA gene with a desired non-coding RNA gene allows for the expression of the desired RNA molecule, which would generally trigger PKR response, without sacrificing RNA polymerase II transcription.</P></DIV></DIV></SECTION><DIV id="mfooter"><H3 class="copyright">Â© 2016 UI iGEM Team. All rights reserved.</H3></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>